Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat
Tango Therapeutics Inc TNGX
$20.04
▼ -0.99%
($-0.20)
Open
$20.61
Prev Close
$20.24
Day Range
$19.79 – $20.61
52W Range
$1.72 – $28.41
Market Cap
$2.90B
Beta
1.17
EPS (TTM)
$-0.83
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-09-03 |
| Shares Out. | 144,650,000 |
| Website | tangotx.com/ ↗ |
| Phone | 13026365400 |
Tango Therapeutics Inc is a publicly traded company under the ticker symbol TNGX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-05-01)
📰 Latest News for TNGX
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Tango Therapeutics (TNGX) Is Down 10.7% After Pipeline Pivot And Board Changes - Has The Bull Case Changed?
Crude Oil Surges 3%; RBC Bearings Earnings Top Views
Mizuho Maintains Outperform on Tango Therapeutics, Raises Price Target to $30
This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
DeFi Technologies, Babcock & Wilcox And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Piper Sandler Downgrades Tango Therapeutics to Neutral, Raises Price Target to $24